Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03594513 |
|
Recruitment Status :
Active, not recruiting
First Posted : July 20, 2018
Last Update Posted : May 1, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Gingival Recession Tooth Abrasion | Procedure: MCAF Procedure: PR Procedure: CTG Procedure: XMD(Mucoderm®) Drug: Sodium dipyrone Drug: chlorhexidine rinse | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 50 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Comparison Between Porcine Acellular Dermal Matrix (Mucoderm®) Versus Connective Tissue Graft in the Treatment of Multiple Adjacent Gingival Recessions Associated With Non-carious Cervical Lesion Partially Restored. |
| Actual Study Start Date : | July 2, 2018 |
| Actual Primary Completion Date : | November 2, 2019 |
| Estimated Study Completion Date : | August 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: MCAF+PR+CTG
The partial restoration of the NCCL will be performed prior the surgeries and will be carried out with composite resin.The surgical procedure for root coverage will be carried out by means modified coronally advanced flap and will be performed by starting with oblique incisions in the interdental areas, which continued with the intrasulcular incision at the recession defects.Each surgical papilla will be dissected in a split-thickness and the envelope flap will be raised with a split-full-split thickness in the coronal-apical direction. Additionally, this group will receive the connective tissue graft harvested from the palate on the recessed area before the sutures.Then, the flap will be coronally positioned and sutured to completely cover the graft.
|
Procedure: MCAF
Periodontal surgical technique to treat gingival recessions.
Other Name: Periodontal plastic surgery Procedure: PR Restorative procedure to treat tooth structure loss.
Other Name: Composite resin restoration Procedure: CTG Autogenous graft harvested from palate placed in the surgical site.
Other Name: Connective tissue graft Drug: Sodium dipyrone All participants were instructed to take 500 mg sodium dipyrone just in case of pain.
Other Name: Drug prescription Drug: chlorhexidine rinse All participants were instructed to perform 0.12% chlorhexidine rinse after the surgical procedures.
Other Name: Drug prescription |
|
Experimental: MCAF+PR+XMD(Mucoderm®)
The partial restoration of the NCCL will be performed prior the surgeries and will be carried out with composite resin.The surgical procedure for root coverage will be carried out by means modified coronally advanced flap and will be performed by starting with oblique incisions in the interdental areas, which continued with the intrasulcular incision at the recession defects.Each surgical papilla will be dissected in a split-thickness and the envelope flap will be raised with a split-full-split thickness in the coronal-apical direction. Additionally, this group will receive a porcine acellular dermal matrix on the recessed area before the sutures. Then, the flap will be coronally positioned and sutured to completely cover the graft.
|
Procedure: MCAF
Periodontal surgical technique to treat gingival recessions.
Other Name: Periodontal plastic surgery Procedure: PR Restorative procedure to treat tooth structure loss.
Other Name: Composite resin restoration Procedure: XMD(Mucoderm®) Xenogenous graft placed in the surgical site.
Other Name: Porcine acellular dermal matrix Drug: Sodium dipyrone All participants were instructed to take 500 mg sodium dipyrone just in case of pain.
Other Name: Drug prescription Drug: chlorhexidine rinse All participants were instructed to perform 0.12% chlorhexidine rinse after the surgical procedures.
Other Name: Drug prescription |
- Percentage of defect coverage [ Time Frame: 6 months ]Percentage mean (%) of root surface covered by the surgical treatment, measured through a periodontal probe.
- Modified root coverage esthetic score [ Time Frame: 6 months ]The Modified Root Coverage Esthetic Scale (MRES; Santamaria et al. 2014) will be performed by two blinded and independent examiners at the 6-month post-operative assessment. This score evaluates six variables: level of the gingival margin, marginal tissue contour, soft tissue texture, mucogingival junction alignment, gingival color, and restoration/cervical lesion color.
- Dentine hypersensitivity [ Time Frame: 6 months ]Evaluation of root sensitivity with the air blow test and measurement with a visual analog scale (VAS).
- Patient recovery [ Time Frame: 14 days ]Evaluation of postsurgery sequelae, pain, and discomfort, oral function and interference with daily activities through postoperative diary previously described (Tonetti et al. 2018).
- Patient-centred esthetic evaluation [ Time Frame: 6 months ]Esthetic evaluation performed by the patient through a visual analog scale (VAS).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- patients presenting three or more Miller class I or II multiple adjacent gingival recessions (recession depth ≥ 2,5 mm) in incisors, canines or premolars associated with non-carious cervical lesion;
- teeth included in the study should present pulp vitality;
- patients presenting no signs of active periodontal disease and full-mouth plaque and bleeding score ≤ 20%;
- patients older than 18 years old;
- probing depth ˂ 3 mm in the included teeth;
- patients who agreed to participate and signed an informed consent form.
Exclusion Criteria:
- patients with systemic problems (cardiovascular, blood dyscrasias, immunodeficiency, and diabetes, among others) that will contraindicate the surgical procedure
- patients taking medications known to interfere with the wound healing process or that contraindicate the surgical procedure
- smokers or pregnant women
- patients who underwent periodontal surgery in the area of interest;
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03594513
| Brazil | |
| São Paulo State University | |
| São José Dos Campos, São Paulo, Brazil, 12245-000 | |
| Principal Investigator: | Mauro P Santamaria, PhD | ICT-UNESP |
| Responsible Party: | Mauro Pedrine Santamaria, Associate professor, Universidade Estadual Paulista Júlio de Mesquita Filho |
| ClinicalTrials.gov Identifier: | NCT03594513 |
| Other Study ID Numbers: |
AR |
| First Posted: | July 20, 2018 Key Record Dates |
| Last Update Posted: | May 1, 2020 |
| Last Verified: | April 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Gingival Recession Tooth Abrasion Mucoderm |
|
Gingival Recession Tooth Abrasion Gingival Diseases Periodontal Diseases Mouth Diseases Stomatognathic Diseases Periodontal Atrophy Tooth Wear Tooth Diseases Dipyrone Chlorhexidine Anti-Infective Agents, Local |
Anti-Infective Agents Disinfectants Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Antipyretics |

